3Sonic is creating a portable medical imaging device that generates high-resolution 3D images of surgical specimens in the operating room for margin analysis. Their technology allows surgeons to assess surgical margins in under five minutes during the procedure, potentially reducing the need for reoperation and additional cancer treatments.
Funding
$526.1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for assessing surgical margins during cancer surgery often rely on traditional pathology, which can be time-consuming and may delay the completion of the procedure. This delay can lead to increased operating room time and the potential need for re-operation if margins are found to be positive for cancer cells.
Solution
3Sonic is developing a real-time 3D ultrasound imaging platform enhanced with artificial intelligence to improve surgical oncology treatment. The platform is designed for rapid margin assessment of surgical specimens directly in the operating room. By providing surgeons with immediate feedback on the presence of cancer cells at the margins, the technology aims to enable faster and more precise decisions during surgery. The goal is to improve outcomes by reducing the likelihood of incomplete resections and the need for subsequent cancer treatments.
Target Audience
The primary target audience includes surgical oncologists, pathologists, and hospitals seeking to improve the precision and efficiency of cancer surgeries.
Features
- Real-time 3D ultrasound imaging for high-resolution visualization of surgical specimens.
- AI-powered analysis for rapid margin assessment and identification of cancerous tissue.
- Portable design for seamless integration into the operating room workflow.
- Intuitive interface for ease of use by surgeons and clinical staff.
- Integration with existing surgical equipment and imaging systems.